XML 77 R64.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMON STOCK, PREFERRED STOCK AND WARRANTS WITH-DOWN ROUND PROTECTION (Schedule of Assumptions Used to Value Options) (Details) - Options Issued to Employees [Member] - $ / shares
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
The following are the data and assumptions used:    
Dividend yield 0.00% 0.00%
Expected volatility [1] 56.59% 62.16%
Risk free interest rate 0.92% 1.08%
Expected term of options   6 years
Share price $ 2.38 [2] $ 2.38 [3]
Fair value   1.01098
Minimum [Member]    
The following are the data and assumptions used:    
Expected term of options 5 years  
Exercise price $ 4.50 4.50
Fair value $ 0.58  
Maximum [Member]    
The following are the data and assumptions used:    
Expected term of options 10 years 6 months  
Exercise price $ 7.75 $ 4.75
Fair value $ 1.28  
[1] Due to the low trading volume of the Company's Common Stock, the expected volatility was based on a sample of 254 companies operating in the Healthcare Products industry.
[2] The Common Stock price, per share for the years ended December 31, 2017 and 2016 reflects the Company's management's estimation of the fair value per share of Common Stock. In reaching its estimation for December 31, 2017, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the 2016 Offering. In reaching its estimation for December 31, 2017, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units.
[3] The Common Stock price, per share for the year ended December 31, 2017 and 2016 reflects the Company's management's estimation of the fair value per share of Common Stock. In reaching its estimation for December 31, 2017, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the 2016 Offering. In reaching its estimation for December 31, 2017, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series C Units.